Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

New lysophosphatidic acid receptor 1 antagonists patented by Humanwell Healthcare

June 3, 2022

New Rho kinase 2 inhibitors identified at Medshine Discovery

June 3, 2022

SMARD1 murine model shows respiratory defects and muscular atrophy

June 2, 2022

Researchers present novel Hermansky-Pudlak syndrome murine model

June 2, 2022

RAGE-silencing RNAi suppresses pulmonary allergic inflammation

May 31, 2022

Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF

May 30, 2022

Sichuan Haisco Pharmaceutical patents ENPP2 inhibitors

May 30, 2022

Pendrin inhibitor ARBM-201 reduces lung injury in acute respiratory distress syndrome model

May 30, 2022

FDA awards orphan drug designation to TTI-101 for IPF

May 27, 2022

ILDONG Pharmaceutical synthesizes new CFTR modulators and/or PDE4 inhibitors

May 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.